nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—Retinal detachment—Memantine—Alzheimer's disease	0.047	0.0589	CcSEcCtD
Latanoprost—Periorbital oedema—Donepezil—Alzheimer's disease	0.0342	0.0428	CcSEcCtD
Latanoprost—Periorbital oedema—Rivastigmine—Alzheimer's disease	0.0304	0.038	CcSEcCtD
Latanoprost—Blepharitis—Donepezil—Alzheimer's disease	0.022	0.0275	CcSEcCtD
Latanoprost—Blepharitis—Memantine—Alzheimer's disease	0.02	0.025	CcSEcCtD
Latanoprost—Blepharitis—Rivastigmine—Alzheimer's disease	0.0195	0.0244	CcSEcCtD
Latanoprost—Embolism—Memantine—Alzheimer's disease	0.0191	0.0239	CcSEcCtD
Latanoprost—Dermatitis atopic—Rivastigmine—Alzheimer's disease	0.0162	0.0203	CcSEcCtD
Latanoprost—Eye irritation—Donepezil—Alzheimer's disease	0.0158	0.0198	CcSEcCtD
Latanoprost—Stinging—Rivastigmine—Alzheimer's disease	0.0148	0.0186	CcSEcCtD
Latanoprost—Dry eye—Donepezil—Alzheimer's disease	0.0125	0.0156	CcSEcCtD
Latanoprost—Inflammation—Rivastigmine—Alzheimer's disease	0.0124	0.0155	CcSEcCtD
Latanoprost—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—APOD—Alzheimer's disease	0.0114	0.0574	CbGpPWpGaD
Latanoprost—Eczema—Donepezil—Alzheimer's disease	0.0109	0.0137	CcSEcCtD
Latanoprost—Bronchitis—Galantamine—Alzheimer's disease	0.0105	0.0132	CcSEcCtD
Latanoprost—Hepatic function abnormal—Memantine—Alzheimer's disease	0.0102	0.0128	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.0102	0.0127	CcSEcCtD
Latanoprost—Eczema—Memantine—Alzheimer's disease	0.00992	0.0124	CcSEcCtD
Latanoprost—Eye pain—Memantine—Alzheimer's disease	0.00987	0.0124	CcSEcCtD
Latanoprost—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—Alzheimer's disease	0.00974	0.0489	CbGpPWpGaD
Latanoprost—Eczema—Rivastigmine—Alzheimer's disease	0.0097	0.0121	CcSEcCtD
Latanoprost—Eye pain—Rivastigmine—Alzheimer's disease	0.00966	0.0121	CcSEcCtD
Latanoprost—Urinary tract infection—Galantamine—Alzheimer's disease	0.00949	0.0119	CcSEcCtD
Latanoprost—Diplopia—Memantine—Alzheimer's disease	0.00891	0.0112	CcSEcCtD
Latanoprost—Diplopia—Rivastigmine—Alzheimer's disease	0.00872	0.0109	CcSEcCtD
Latanoprost—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00861	0.0108	CcSEcCtD
Latanoprost—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—Alzheimer's disease	0.00849	0.0426	CbGpPWpGaD
Latanoprost—Asthma—Donepezil—Alzheimer's disease	0.00848	0.0106	CcSEcCtD
Latanoprost—Angina pectoris—Donepezil—Alzheimer's disease	0.00826	0.0103	CcSEcCtD
Latanoprost—Bronchitis—Donepezil—Alzheimer's disease	0.00816	0.0102	CcSEcCtD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS1—Alzheimer's disease	0.00804	0.0403	CbGpPWpGaD
Latanoprost—Asthma—Memantine—Alzheimer's disease	0.0077	0.00964	CcSEcCtD
Latanoprost—Angina pectoris—Memantine—Alzheimer's disease	0.0075	0.00939	CcSEcCtD
Latanoprost—SLCO2B1—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.00747	0.0375	CbGpPWpGaD
Latanoprost—Bronchitis—Memantine—Alzheimer's disease	0.00741	0.00927	CcSEcCtD
Latanoprost—Back pain—Galantamine—Alzheimer's disease	0.00738	0.00923	CcSEcCtD
Latanoprost—Urinary tract infection—Donepezil—Alzheimer's disease	0.00735	0.0092	CcSEcCtD
Latanoprost—Conjunctivitis—Donepezil—Alzheimer's disease	0.00735	0.0092	CcSEcCtD
Latanoprost—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00734	0.00919	CcSEcCtD
Latanoprost—Bronchitis—Rivastigmine—Alzheimer's disease	0.00725	0.00907	CcSEcCtD
Latanoprost—Vision blurred—Galantamine—Alzheimer's disease	0.00719	0.009	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00716	0.00896	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.007	0.00876	CcSEcCtD
Latanoprost—Conjunctivitis—Memantine—Alzheimer's disease	0.00668	0.00835	CcSEcCtD
Latanoprost—Urinary tract infection—Memantine—Alzheimer's disease	0.00668	0.00835	CcSEcCtD
Latanoprost—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00653	0.00817	CcSEcCtD
Latanoprost—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00653	0.00817	CcSEcCtD
Latanoprost—Arthralgia—Galantamine—Alzheimer's disease	0.00649	0.00813	CcSEcCtD
Latanoprost—Chest pain—Galantamine—Alzheimer's disease	0.00649	0.00813	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00645	0.00807	CcSEcCtD
Latanoprost—Discomfort—Galantamine—Alzheimer's disease	0.00642	0.00803	CcSEcCtD
Latanoprost—Nervous system disorder—Galantamine—Alzheimer's disease	0.0061	0.00764	CcSEcCtD
Latanoprost—Connective tissue disorder—Memantine—Alzheimer's disease	0.00606	0.00758	CcSEcCtD
Latanoprost—Skin disorder—Galantamine—Alzheimer's disease	0.00605	0.00757	CcSEcCtD
Latanoprost—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00593	0.00742	CcSEcCtD
Latanoprost—Erythema—Donepezil—Alzheimer's disease	0.00591	0.0074	CcSEcCtD
Latanoprost—Back pain—Donepezil—Alzheimer's disease	0.00572	0.00716	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00567	0.0071	CcSEcCtD
Latanoprost—Vision blurred—Donepezil—Alzheimer's disease	0.00557	0.00697	CcSEcCtD
Latanoprost—SLC22A1—Neurotransmitter Release Cycle—SLC18A3—Alzheimer's disease	0.00557	0.0279	CbGpPWpGaD
Latanoprost—Mediastinal disorder—Memantine—Alzheimer's disease	0.00556	0.00695	CcSEcCtD
Latanoprost—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00544	0.0068	CcSEcCtD
Latanoprost—Erythema—Rivastigmine—Alzheimer's disease	0.00525	0.00657	CcSEcCtD
Latanoprost—Back pain—Memantine—Alzheimer's disease	0.00519	0.0065	CcSEcCtD
Latanoprost—Back pain—Rivastigmine—Alzheimer's disease	0.00508	0.00636	CcSEcCtD
Latanoprost—Vision blurred—Memantine—Alzheimer's disease	0.00506	0.00633	CcSEcCtD
Latanoprost—Arthralgia—Donepezil—Alzheimer's disease	0.00503	0.0063	CcSEcCtD
Latanoprost—Chest pain—Donepezil—Alzheimer's disease	0.00503	0.0063	CcSEcCtD
Latanoprost—Discomfort—Donepezil—Alzheimer's disease	0.00497	0.00622	CcSEcCtD
Latanoprost—Vision blurred—Rivastigmine—Alzheimer's disease	0.00495	0.00619	CcSEcCtD
Latanoprost—Oedema—Donepezil—Alzheimer's disease	0.00482	0.00604	CcSEcCtD
Latanoprost—Nervous system disorder—Donepezil—Alzheimer's disease	0.00473	0.00592	CcSEcCtD
Latanoprost—Chest pain—Memantine—Alzheimer's disease	0.00457	0.00572	CcSEcCtD
Latanoprost—Arthralgia—Memantine—Alzheimer's disease	0.00457	0.00572	CcSEcCtD
Latanoprost—Discomfort—Memantine—Alzheimer's disease	0.00451	0.00565	CcSEcCtD
Latanoprost—Chest pain—Rivastigmine—Alzheimer's disease	0.00447	0.00559	CcSEcCtD
Latanoprost—Arthralgia—Rivastigmine—Alzheimer's disease	0.00447	0.00559	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00444	0.00556	CcSEcCtD
Latanoprost—Discomfort—Rivastigmine—Alzheimer's disease	0.00442	0.00553	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.0044	0.0055	CcSEcCtD
Latanoprost—Oedema—Memantine—Alzheimer's disease	0.00438	0.00548	CcSEcCtD
Latanoprost—Dyspnoea—Donepezil—Alzheimer's disease	0.0043	0.00538	CcSEcCtD
Latanoprost—Nervous system disorder—Memantine—Alzheimer's disease	0.0043	0.00538	CcSEcCtD
Latanoprost—Oedema—Rivastigmine—Alzheimer's disease	0.00429	0.00536	CcSEcCtD
Latanoprost—Skin disorder—Memantine—Alzheimer's disease	0.00425	0.00532	CcSEcCtD
Latanoprost—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.0042	0.00526	CcSEcCtD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.00417	0.0209	CbGpPWpGaD
Latanoprost—Skin disorder—Rivastigmine—Alzheimer's disease	0.00416	0.00521	CcSEcCtD
Latanoprost—Pain—Donepezil—Alzheimer's disease	0.00413	0.00516	CcSEcCtD
Latanoprost—Dizziness—Galantamine—Alzheimer's disease	0.00412	0.00515	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00399	0.00499	CcSEcCtD
Latanoprost—Rash—Galantamine—Alzheimer's disease	0.00392	0.00491	CcSEcCtD
Latanoprost—Dermatitis—Galantamine—Alzheimer's disease	0.00392	0.00491	CcSEcCtD
Latanoprost—Dyspnoea—Memantine—Alzheimer's disease	0.00391	0.00489	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.0039	0.00489	CcSEcCtD
Latanoprost—Headache—Galantamine—Alzheimer's disease	0.0039	0.00488	CcSEcCtD
Latanoprost—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00382	0.00478	CcSEcCtD
Latanoprost—Pain—Memantine—Alzheimer's disease	0.00375	0.00469	CcSEcCtD
Latanoprost—Pain—Rivastigmine—Alzheimer's disease	0.00366	0.00459	CcSEcCtD
Latanoprost—Pruritus—Donepezil—Alzheimer's disease	0.00341	0.00427	CcSEcCtD
Latanoprost—SLC22A1—Neurotransmitter Release Cycle—CHAT—Alzheimer's disease	0.00333	0.0167	CbGpPWpGaD
Latanoprost—Dizziness—Donepezil—Alzheimer's disease	0.00319	0.00399	CcSEcCtD
Latanoprost—Pruritus—Memantine—Alzheimer's disease	0.0031	0.00388	CcSEcCtD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—Alzheimer's disease	0.00308	0.0154	CbGpPWpGaD
Latanoprost—Rash—Donepezil—Alzheimer's disease	0.00304	0.00381	CcSEcCtD
Latanoprost—Dermatitis—Donepezil—Alzheimer's disease	0.00304	0.0038	CcSEcCtD
Latanoprost—Pruritus—Rivastigmine—Alzheimer's disease	0.00303	0.00379	CcSEcCtD
Latanoprost—Headache—Donepezil—Alzheimer's disease	0.00302	0.00378	CcSEcCtD
Latanoprost—Dizziness—Memantine—Alzheimer's disease	0.0029	0.00363	CcSEcCtD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.00289	0.0145	CbGpPWpGaD
Latanoprost—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A6—Alzheimer's disease	0.00285	0.0143	CbGpPWpGaD
Latanoprost—Dizziness—Rivastigmine—Alzheimer's disease	0.00283	0.00355	CcSEcCtD
Latanoprost—Rash—Memantine—Alzheimer's disease	0.00276	0.00346	CcSEcCtD
Latanoprost—Dermatitis—Memantine—Alzheimer's disease	0.00276	0.00345	CcSEcCtD
Latanoprost—Headache—Memantine—Alzheimer's disease	0.00274	0.00343	CcSEcCtD
Latanoprost—Rash—Rivastigmine—Alzheimer's disease	0.0027	0.00338	CcSEcCtD
Latanoprost—Dermatitis—Rivastigmine—Alzheimer's disease	0.0027	0.00338	CcSEcCtD
Latanoprost—Headache—Rivastigmine—Alzheimer's disease	0.00268	0.00336	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.00247	0.0124	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.00246	0.0123	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.00241	0.0121	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.00238	0.0119	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.00212	0.0106	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.00206	0.0104	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Other—CCR5—Alzheimer's disease	0.00203	0.0102	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Other—HTR2A—Alzheimer's disease	0.00199	0.00998	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—PYY—Alzheimer's disease	0.00188	0.00944	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.00187	0.00937	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—NPS—Alzheimer's disease	0.00186	0.00933	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—APP—Alzheimer's disease	0.00173	0.00867	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.00171	0.0086	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—Alzheimer's disease	0.00166	0.00834	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—PLCB1—Alzheimer's disease	0.00163	0.00818	CbGpPWpGaD
Latanoprost—Tafluprost—PTGS2—Alzheimer's disease	0.0016	1	CrCbGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.0016	0.00801	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—HTR6—Alzheimer's disease	0.00157	0.00788	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—APP—Alzheimer's disease	0.00155	0.00775	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.00154	0.00774	CbGpPWpGaD
Latanoprost—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Alzheimer's disease	0.00152	0.00763	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.00147	0.00737	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.00146	0.00732	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.00135	0.00675	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—GAL—Alzheimer's disease	0.0013	0.00655	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.00129	0.0065	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.00125	0.00626	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.00123	0.00618	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—SLC18A3—Alzheimer's disease	0.00122	0.00614	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.00117	0.00589	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.00114	0.00574	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.00113	0.00565	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.00113	0.00565	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.00112	0.00561	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.0011	0.00552	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.00107	0.00534	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PYY—Alzheimer's disease	0.00106	0.00534	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—NPY—Alzheimer's disease	0.00103	0.00514	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—IAPP—Alzheimer's disease	0.00102	0.00511	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.001	0.00502	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CRH—Alzheimer's disease	0.000989	0.00496	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—F2—Alzheimer's disease	0.00098	0.00492	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PYY—Alzheimer's disease	0.000966	0.00485	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000957	0.0048	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000957	0.0048	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000949	0.00476	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—NPS—Alzheimer's disease	0.000938	0.0047	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—SST—Alzheimer's disease	0.000894	0.00449	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000888	0.00445	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000883	0.00443	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.000877	0.0044	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—APP—Alzheimer's disease	0.000872	0.00437	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000864	0.00434	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—GRIK1—Alzheimer's disease	0.000862	0.00433	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—CHRNA7—Alzheimer's disease	0.000862	0.00433	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000853	0.00428	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CDK5—Alzheimer's disease	0.000838	0.0042	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000808	0.00405	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HTR6—Alzheimer's disease	0.000806	0.00404	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.000799	0.00401	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000784	0.00393	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000757	0.0038	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000742	0.00372	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000741	0.00372	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—GAL—Alzheimer's disease	0.000737	0.0037	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000733	0.00368	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—CHAT—Alzheimer's disease	0.000733	0.00368	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—GRIK2—Alzheimer's disease	0.000733	0.00368	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000691	0.00347	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GAL—Alzheimer's disease	0.00067	0.00336	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000667	0.00334	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000658	0.0033	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—GRIA1—Alzheimer's disease	0.000653	0.00328	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TTR—Alzheimer's disease	0.000653	0.00328	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000649	0.00326	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000646	0.00324	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000631	0.00316	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—CHRNB2—Alzheimer's disease	0.000619	0.0031	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000617	0.00309	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.00061	0.00306	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—NPY—Alzheimer's disease	0.000579	0.00291	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000579	0.0029	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCR5—Alzheimer's disease	0.000576	0.00289	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000576	0.00289	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PYY—Alzheimer's disease	0.000571	0.00286	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—ACHE—Alzheimer's disease	0.000568	0.00285	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000564	0.00283	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—CHRNA4—Alzheimer's disease	0.000562	0.00282	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000559	0.00281	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CRH—Alzheimer's disease	0.000559	0.0028	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—NPS—Alzheimer's disease	0.00053	0.00266	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—NPY—Alzheimer's disease	0.000526	0.00264	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IAPP—Alzheimer's disease	0.000523	0.00262	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CRH—Alzheimer's disease	0.000508	0.00255	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000505	0.00254	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—SST—Alzheimer's disease	0.000505	0.00254	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—BCHE—Alzheimer's disease	0.000495	0.00248	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDK5—Alzheimer's disease	0.000495	0.00248	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—F2—Alzheimer's disease	0.000494	0.00248	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—APP—Alzheimer's disease	0.000493	0.00247	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—DLG4—Alzheimer's disease	0.000483	0.00242	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—NPS—Alzheimer's disease	0.000481	0.00241	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000479	0.0024	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HTR6—Alzheimer's disease	0.000476	0.00239	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—GRIN2B—Alzheimer's disease	0.000472	0.00237	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—PLCB1—Alzheimer's disease	0.000467	0.00234	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000466	0.00234	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000465	0.00233	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GAB2—Alzheimer's disease	0.000459	0.0023	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—SST—Alzheimer's disease	0.000459	0.0023	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000451	0.00226	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—APP—Alzheimer's disease	0.000447	0.00224	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—DHCR24—Alzheimer's disease	0.000445	0.00223	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCL2—Alzheimer's disease	0.000441	0.00221	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PSENEN—Alzheimer's disease	0.000433	0.00217	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APH1A—Alzheimer's disease	0.000427	0.00214	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000422	0.00212	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NCSTN—Alzheimer's disease	0.000415	0.00208	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LRP1—Alzheimer's disease	0.000405	0.00203	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GFAP—Alzheimer's disease	0.000396	0.00198	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GAL—Alzheimer's disease	0.000396	0.00198	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.00039	0.00196	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CA4—Alzheimer's disease	0.000378	0.0019	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GAPDHS—Alzheimer's disease	0.000355	0.00178	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000351	0.00176	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—A2M—Alzheimer's disease	0.000349	0.00175	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000347	0.00174	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—PRKCG—Alzheimer's disease	0.000346	0.00173	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000344	0.00172	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PSEN2—Alzheimer's disease	0.000338	0.00169	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ATP5A1—Alzheimer's disease	0.000337	0.00169	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000334	0.00168	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000326	0.00163	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PLD3—Alzheimer's disease	0.000321	0.00161	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000319	0.0016	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000312	0.00157	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NPY—Alzheimer's disease	0.000311	0.00156	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IAPP—Alzheimer's disease	0.000309	0.00155	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HSD17B10—Alzheimer's disease	0.000308	0.00155	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CRH—Alzheimer's disease	0.0003	0.0015	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—CALM1—Alzheimer's disease	0.000299	0.0015	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000299	0.0015	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP46A1—Alzheimer's disease	0.000297	0.00149	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCR5—Alzheimer's disease	0.000296	0.00148	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000289	0.00145	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ND1—Alzheimer's disease	0.000287	0.00144	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NPS—Alzheimer's disease	0.000284	0.00143	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000283	0.00142	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—F2—Alzheimer's disease	0.000279	0.0014	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTK2B—Alzheimer's disease	0.000279	0.0014	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SST—Alzheimer's disease	0.000271	0.00136	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GAB2—Alzheimer's disease	0.000271	0.00136	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NTRK2—Alzheimer's disease	0.000271	0.00136	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CALM1—Alzheimer's disease	0.00027	0.00135	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GSK3A—Alzheimer's disease	0.000269	0.00135	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APP—Alzheimer's disease	0.000264	0.00133	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—CREB1—Alzheimer's disease	0.000256	0.00128	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—F2—Alzheimer's disease	0.000254	0.00127	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PLCB1—Alzheimer's disease	0.000249	0.00125	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NGFR—Alzheimer's disease	0.000233	0.00117	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CREB1—Alzheimer's disease	0.000231	0.00116	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADAM10—Alzheimer's disease	0.000227	0.00114	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCL2—Alzheimer's disease	0.000226	0.00113	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—S100B—Alzheimer's disease	0.000215	0.00108	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000209	0.00105	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF2—Alzheimer's disease	0.000205	0.00103	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF1R—Alzheimer's disease	0.000198	0.000992	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LPL—Alzheimer's disease	0.00019	0.000951	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MEF2C—Alzheimer's disease	0.000188	0.000943	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CHAT—Alzheimer's disease	0.000185	0.000926	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TPI1—Alzheimer's disease	0.000185	0.000926	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKCG—Alzheimer's disease	0.000184	0.000925	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NGF—Alzheimer's disease	0.00018	0.000901	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MAOB—Alzheimer's disease	0.000177	0.000888	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCR5—Alzheimer's disease	0.000175	0.000876	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HTR2A—Alzheimer's disease	0.000171	0.000858	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GAPDH—Alzheimer's disease	0.00017	0.000855	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—A2M—Alzheimer's disease	0.000165	0.000825	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CALM1—Alzheimer's disease	0.00016	0.0008	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LEP—Alzheimer's disease	0.000159	0.000797	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOE—Alzheimer's disease	0.000159	0.000797	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CAV1—Alzheimer's disease	0.000157	0.00079	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ESR1—Alzheimer's disease	0.000152	0.000761	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—F2—Alzheimer's disease	0.00015	0.000752	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000147	0.000736	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ACHE—Alzheimer's disease	0.000143	0.000718	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—INPP5D—Alzheimer's disease	0.000142	0.00071	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GSK3B—Alzheimer's disease	0.000138	0.000691	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CREB1—Alzheimer's disease	0.000137	0.000685	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—INS—Alzheimer's disease	0.000136	0.000681	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ENO1—Alzheimer's disease	0.000134	0.000673	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS1—Alzheimer's disease	0.000134	0.000673	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCL2—Alzheimer's disease	0.000134	0.00067	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2D6—Alzheimer's disease	0.000132	0.00066	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF1—Alzheimer's disease	0.000131	0.000659	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—BCHE—Alzheimer's disease	0.000125	0.000626	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOS3—Alzheimer's disease	0.000119	0.000597	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PLCB1—Alzheimer's disease	0.000118	0.00059	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCA1—Alzheimer's disease	0.000114	0.000572	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000102	0.000512	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CASP3—Alzheimer's disease	0.000101	0.000507	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6—Alzheimer's disease	0.0001	0.000504	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARGC1A—Alzheimer's disease	9.83e-05	0.000493	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMOX1—Alzheimer's disease	9.79e-05	0.000491	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK8—Alzheimer's disease	9.29e-05	0.000466	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT1—Alzheimer's disease	9.27e-05	0.000465	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LPL—Alzheimer's disease	8.95e-05	0.000449	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—Alzheimer's disease	8.58e-05	0.00043	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTHFR—Alzheimer's disease	8.06e-05	0.000404	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFB1—Alzheimer's disease	7.87e-05	0.000395	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CALM1—Alzheimer's disease	7.53e-05	0.000378	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOE—Alzheimer's disease	7.5e-05	0.000376	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CAV1—Alzheimer's disease	7.43e-05	0.000373	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARG—Alzheimer's disease	6.53e-05	0.000328	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TP53—Alzheimer's disease	6.48e-05	0.000325	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—INS—Alzheimer's disease	6.41e-05	0.000322	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6—Alzheimer's disease	5.93e-05	0.000298	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NOS3—Alzheimer's disease	5.62e-05	0.000282	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT1—Alzheimer's disease	5.47e-05	0.000275	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	5.14e-05	0.000258	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKT1—Alzheimer's disease	2.58e-05	0.00013	CbGpPWpGaD
